Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1990 1
1995 1
1996 1
1998 1
2001 3
2002 1
2004 5
2005 2
2007 3
2008 2
2009 4
2010 3
2011 4
2012 9
2013 3
2014 4
2015 6
2016 7
2017 6
2018 4
2019 7
2020 3
2021 5
2022 7
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients.
Diray-Arce J, Fourati S, Doni Jayavelu N, Patel R, Maguire C, Chang AC, Dandekar R, Qi J, Lee BH, van Zalm P, Schroeder A, Chen E, Konstorum A, Brito A, Gygi JP, Kho A, Chen J, Pawar S, Gonzalez-Reiche AS, Hoch A, Milliren CE, Overton JA, Westendorf K; IMPACC Network; Cairns CB, Rouphael N, Bosinger SE, Kim-Schulze S, Krammer F, Rosen L, Grubaugh ND, van Bakel H, Wilson M, Rajan J, Steen H, Eckalbar W, Cotsapas C, Langelier CR, Levy O, Altman MC, Maecker H, Montgomery RR, Haddad EK, Sekaly RP, Esserman D, Ozonoff A, Becker PM, Augustine AD, Guan L, Peters B, Kleinstein SH. Diray-Arce J, et al. Cell Rep Med. 2023 Jun 20;4(6):101079. doi: 10.1016/j.xcrm.2023.101079. Epub 2023 May 23. Cell Rep Med. 2023. PMID: 37327781 Free PMC article.
The IMPACC cohort, composed of >1,000 hospitalized COVID-19 participants, contains five illness trajectory groups (TGs) during acute infection (first 28 days), ranging from milder (TG1-3) to more severe disease course (TG4) and death (TG5). Here, we report deep immunoph …
The IMPACC cohort, composed of >1,000 hospitalized COVID-19 participants, contains five illness trajectory groups (TGs) during acute infe …
Transglutaminase-5 related schizophrenia.
Joe P, Getz M, Redman S, Kranz TM, Chao MV, Delaney S, Chen LA, Malaspina D. Joe P, et al. Schizophr Res. 2018 Mar;193:477-479. doi: 10.1016/j.schres.2017.08.004. Epub 2017 Aug 7. Schizophr Res. 2018. PMID: 28797525 No abstract available.
TIP60 is required for tumorigenesis in non-small cell lung cancer.
Shibahara D, Akanuma N, Kobayashi IS, Heo E, Ando M, Fujii M, Jiang F, Prin PN, Pan G, Wong KK, Costa DB, Bararia D, Tenen DG, Watanabe H, Kobayashi SS. Shibahara D, et al. Cancer Sci. 2023 Jun;114(6):2400-2413. doi: 10.1111/cas.15785. Epub 2023 Apr 18. Cancer Sci. 2023. PMID: 36916958 Free PMC article.
RNA-seq and ChIP-seq analyses of inducible TIP60 knockdown H1975 cells relative to controls revealed transglutaminase enzyme (TGM5) as downstream of TIP60. Investigation of a connectivity map database identified several candidate compounds that decrease TIP60 mRNA, one tha …
RNA-seq and ChIP-seq analyses of inducible TIP60 knockdown H1975 cells relative to controls revealed transglutaminase enzyme (TGM5) a …
Transglutaminases in autoimmune and inherited skin diseases: The phenomena of epitope spreading and functional compensation.
Kárpáti S, Sárdy M, Németh K, Mayer B, Smyth N, Paulsson M, Traupe H. Kárpáti S, et al. Exp Dermatol. 2018 Aug;27(8):807-814. doi: 10.1111/exd.13449. Epub 2018 Feb 26. Exp Dermatol. 2018. PMID: 28940785 Review.
In this study, skin diseases induced by genetic damages or autoimmune targeting of these enzymes will be discussed. TG1, TG3 and TG5 contribute to the cutaneous barrier and thus to the integrity and function of epidermis. TGM1 mutations related to autosomal recessive ichth …
In this study, skin diseases induced by genetic damages or autoimmune targeting of these enzymes will be discussed. TG1, TG3 and TG5
Expressions of isopeptide bonds and corneodesmosin in middle ear cholesteatoma.
Koizumi H, Kawaguchi R, Ohkubo JI, Ikezaki S, Kitamura T, Hohchi N, Hashida K, Suzuki H. Koizumi H, et al. Clin Otolaryngol. 2017 Apr;42(2):252-262. doi: 10.1111/coa.12703. Epub 2016 Jul 21. Clin Otolaryngol. 2017. PMID: 27390311
MAIN OUTCOME MEASURES: Expression of e-(g-glutamyl)lysine isopeptide bonds was examined by immunohistochemistry; Expressions of transglutaminase (TGase)1, TGase2, TGase3, and TGase5 by immunohistochemistry and quantitative RT-PCR (qRT-PCR); expression of CDSN by immunohist …
MAIN OUTCOME MEASURES: Expression of e-(g-glutamyl)lysine isopeptide bonds was examined by immunohistochemistry; Expressions of transglutami …
Association between TGM5, PPAP2B and PSMA4 polymorphisms and NSCLC in never-smoking Chinese population.
Yongjun Zhang MM, Zhang A, Hua Shi MM, Xiangming Kong MM. Yongjun Zhang MM, et al. J Cancer Res Ther. 2013 Oct-Dec;9(4):660-3. doi: 10.4103/0973-1482.126473. J Cancer Res Ther. 2013. PMID: 24518713 Free article.
AIM: To explore the potential association between SNPs in transglutaminase 5 (TGM5), phosphatidic acid phosphatase type 2B (PPAP2B) and proteasome subunit, alpha type 4 (PSMA4) and non-small cell lung cancer (NSCLC) susceptibility in Chinese patients who were …
AIM: To explore the potential association between SNPs in transglutaminase 5 (TGM5), phosphatidic acid phosphatase type …
A homozygous missense mutation in TGM5 abolishes epidermal transglutaminase 5 activity and causes acral peeling skin syndrome.
Cassidy AJ, van Steensel MA, Steijlen PM, van Geel M, van der Velden J, Morley SM, Terrinoni A, Melino G, Candi E, McLean WH. Cassidy AJ, et al. Am J Hum Genet. 2005 Dec;77(6):909-17. doi: 10.1086/497707. Epub 2005 Oct 11. Am J Hum Genet. 2005. PMID: 16380904 Free PMC article.
Two homozygous missense mutations, T109M and G113C, were found in TGM5, which encodes transglutaminase 5 (TG5), in all affected persons in two unrelated families. ...Other families with more-widespread peeling skin phenotypes lacked TGM5 mutatio …
Two homozygous missense mutations, T109M and G113C, were found in TGM5, which encodes transglutaminase 5 (TG5), …
Olfactory bulb atrophy and caspase activation observed in the BACHD rat models of Huntington disease.
Lessard-Beaudoin M, Yu-Taeger L, Laroche M, Singer E, Riess O, Nguyen HHP, Graham RK. Lessard-Beaudoin M, et al. Neurobiol Dis. 2019 May;125:219-231. doi: 10.1016/j.nbd.2019.02.002. Epub 2019 Feb 6. Neurobiol Dis. 2019. PMID: 30738141
In order to determine if alterations in the olfactory bulb (OB) are observed in HD we assessed OB weight or area from 3 to 12 months of age in the BACHD transgenic lines (TG5 and TG9). A significant decrease in the OB was observed at 6 and 12 months of age compared to WT. …
In order to determine if alterations in the olfactory bulb (OB) are observed in HD we assessed OB weight or area from 3 to 12 months of age …
Transglutaminase 5 is regulated by guanine-adenine nucleotides.
Candi E, Paradisi A, Terrinoni A, Pietroni V, Oddi S, Cadot B, Jogini V, Meiyappan M, Clardy J, Finazzi-Agro A, Melino G. Candi E, et al. Biochem J. 2004 Jul 1;381(Pt 1):313-9. doi: 10.1042/BJ20031474. Biochem J. 2004. PMID: 15038793 Free PMC article.
GTP and ATP inhibit TGase5 cross-linking activity in vitro, and Ca2+ is capable of completely reversing this inhibition. In addition, TGase5 mRNA is not restricted to epidermal tissue, but is also present in different adult and foetal tissues, suggesting a role for …
GTP and ATP inhibit TGase5 cross-linking activity in vitro, and Ca2+ is capable of completely reversing this inhibition. In addition, …
RATIONAL FOR CONTINUING TERLIPRESSIN AFTER ENDOSCOPIC VARICEAL LIGATION IN ACUTE VARICEAL HAEMORRHAGE NEEDS FURTHER EVIDENCE: A PILOT STUDY.
Poudel RC, Dhibar DP, Sharma N, Sharma V, Taneja S, Prakash A. Poudel RC, et al. Arq Gastroenterol. 2022 Jan-Mar;59(1):89-96. doi: 10.1590/S0004-2803.202200001-16. Arq Gastroenterol. 2022. PMID: 35442343 Free article. Clinical Trial.
RESULTS: A total of 9 (12.6%) patients had re-bleed with maximum 4 (5.6%) patients in TG5 group followed by 3 (4.2%) in TG2 and 2 (2.8%) in TG0 groups (P=0.670). The overall mortality was 15 (21.1%) patients, 6 (8.5%) patients in TG0 group, followed by 5 (7.0%) in TG5
RESULTS: A total of 9 (12.6%) patients had re-bleed with maximum 4 (5.6%) patients in TG5 group followed by 3 (4.2%) in TG2 and 2 (2. …
87 results